These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35079378)

  • 1. Retrospective analysis of the efficacy of adjuvant cytokine-induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery.
    Li X; Zhou H; Huang W; Wang X; Meng M; Hou Z; Liao L; Tang W; Xie Y; Wang R; Yu H; Wang L; Zhu H; Wang W; Tan J; Li R
    Clin Transl Immunology; 2022; 11(1):e1368. PubMed ID: 35079378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection.
    Pan QZ; Zhao JJ; Yang CP; Zhou YQ; Lin JZ; Tang Y; Gu JM; Wang QJ; Li YQ; He J; Chen SP; Song MJ; Huang Y; Yang JY; Weng DS; Xia JC
    Oncoimmunology; 2020; 9(1):1752563. PubMed ID: 32363125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy.
    Zhou Y; Chen CL; Jiang SW; Feng Y; Yuan L; Chen P; Zhang L; Huang S; Li J; Xia JC; Zheng M
    Oncoimmunology; 2019; 8(2):e1528411. PubMed ID: 30713783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer.
    Pan QZ; Tang Y; Wang QJ; Li YQ; Zhang L; Li XD; Zhao JJ; Weng DS; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
    Oncoimmunology; 2015 Sep; 4(9):e1038017. PubMed ID: 26405607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer.
    Yang X; Weng D; Pan Q; Xiang T; Yang C; Wu Z; Li M; Xie S; Tang Y; Xia J; Zhao J
    Front Immunol; 2022; 13():974487. PubMed ID: 36439119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.
    Zhao H; Fan Y; Li H; Yu J; Liu L; Cao S; Ren B; Yan F; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):303-9. PubMed ID: 23506427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Clinical Efficacy of Dendritic Cell -cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer.
    Xu H; Qin W; Feng H; Song D; Yang X; Zhang J
    Immunol Invest; 2021 Aug; 50(6):622-633. PubMed ID: 32718264
    [No Abstract]   [Full Text] [Related]  

  • 8. Retrospective analysis of the efficacy of cytokine-induced killer cell immunotherapy combined with first-line chemotherapy in patients with metastatic colorectal cancer.
    Pan QZ; Gu JM; Zhao JJ; Tang Y; Wang QJ; Zhu Q; Song MJ; Li YQ; He J; Chen SP; Weng DS; Xia JC
    Clin Transl Immunology; 2020; 9(2):e1113. PubMed ID: 32076550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
    Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
    Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
    Lin T; Song C; Chuo DY; Zhang H; Zhao J
    Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy.
    Chen Y; Guo ZQ; Shi CM; Zhou ZF; Ye YB; Chen Q
    Int J Clin Exp Med; 2015; 8(5):7728-36. PubMed ID: 26221323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
    Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
    Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
    Pan K; Guan XX; Li YQ; Zhao JJ; Li JJ; Qiu HJ; Weng DS; Wang QJ; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
    Clin Cancer Res; 2014 Jun; 20(11):3003-11. PubMed ID: 24668644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer.
    Wang Y; Wang C; Xiao H; Niu C; Wu H; Jin H; Yao C; He H; Tian H; Han F; Li D; Han W; Xu J; Chen J; Cui J; Li W
    Cancer Med; 2017 Jan; 6(1):45-53. PubMed ID: 27790867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells.
    Chen Y; Lin J; Guo ZQ; Lin WS; Zhou ZF; Huang CZ; Chen Q; Ye YB
    Am J Cancer Res; 2015; 5(10):3221-30. PubMed ID: 26693072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer.
    Zhou ZQ; Zhao JJ; Pan QZ; Chen CL; Liu Y; Tang Y; Zhu Q; Weng DS; Xia JC
    J Immunother Cancer; 2019 Aug; 7(1):228. PubMed ID: 31455411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis.
    Li CMY; Tomita Y; Dhakal B; Li R; Li J; Drew P; Price T; Smith E; Maddern GJ; Fenix KA
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37117007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial.
    Zhao H; Wang Y; Yu J; Wei F; Cao S; Zhang X; Dong N; Li H; Ren X
    Clin Colorectal Cancer; 2016 Sep; 15(3):228-35. PubMed ID: 27052743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of cytokine-induced killer cell-based immunotherapy for hepatocellular carcinoma.
    Jia CC; Chen YH; Cai XR; Li Y; Zheng XF; Yao ZC; Zhao LY; Qiu DB; Xie SJ; Chen WJ; Liu C; Liu QL; Wu XY; Wang TT; Zhang Q
    Am J Cancer Res; 2019; 9(6):1254-1265. PubMed ID: 31285957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.